Comparison of Buprenorphine and Methadone - 3

Pharmacological Comparison of Buprenorphine and Methadone

Status

Completed

Phases

Phase 2

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00000334

Enrollment

Registered

1999-09-21

Start date

2002-12-01

Completion date

2005-01-15

Last updated

2017-01-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Opioid-Related Disorders

Brief summary

The purpose of this study is to compare agonist and antagonist profile associated with buprenorphine vs. methadone during opiate withdrawal.

Interventions

DRUGBuprenorphine

Study design

Primary purpose

TREATMENT

Eligibility

Sex/Gender

MALE

Age

23 Years to 45 Years

Healthy volunteers

Inclusion criteria

Please contact site for information.

Design outcomes

Primary

Measure	Time frame
Withdrawal severity	—
Opiate agonist symptoms	—

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026